2026 -- S 2385

========

LC004629

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2026

____________

A N   A C T

RELATING TO HUMAN SERVICES -- MEDICAL ASSISTANCE -- PRESCRIPTION

DRUGS

     

     Introduced By: Senators Bissaillon, Murray, LaMountain, and DiMario

     Date Introduced: January 30, 2026

     Referred To: Senate Health & Human Services

     It is enacted by the General Assembly as follows:

1

     SECTION 1. Chapter 40-21 of the General Laws entitled "Medical Assistance —

2

Prescription Drugs" is hereby amended by adding thereto the following section:

3

     40-21-4. Prohibition of prior authorization or step therapy protocol.

4

     (a) The Rhode Island medical assistance program, as defined under chapter 8 of this title,

5

and any contract between the Rhode Island medical assistance program and a managed care

6

organization shall not require prior authorization or a step therapy protocol for the coverage of a

7

medication classified as an anticonvulsant or antipsychotic on their drug formulary.

8

     (b) If the secretary of the executive office of health and human services determines that

9

authorization from a federal agency is necessary for the implementation of this section, the

10

secretary is authorized to seek such state plan amendment and may delay implementing the

11

provisions until the authorization is granted.

12

     (c) The Rhode Island medical assistance program shall require, through amending current

13

and future medical assistance managed care contracts, that the managed care organizations meet

14

the provisions of this section.

15

     (d) The provisions of subsection (a) of this section do not affect clinical prior authorization

16

edits to prescriptions of medications classified as an anticonvulsant or antipsychotic.

17

     (e) This section does not prevent the Rhode Island medical assistance program and any

18

contract between the Rhode Island medical assistance program and a managed care organization

 

1

from denying a medication that has been removed from the market due to safety concerns from the

2

federal Food and Drug Administration.

3

     (f) For the purposes of this section, "step therapy protocol" means a protocol that

4

establishes a specific sequence in which prescription medications for a specified medical condition

5

are medically necessary for a particular enrollee and are covered under a pharmacy or medical

6

benefit by the Rhode Island medical assistance program or a managed care organization, including

7

self-administered and physician-administered drugs.

8

     (g) On or before July 1, 2029, the Rhode Island medical assistance program and any

9

managed care organization that has a contract with the Rhode Island medical assistance program

10

shall collect and provide to the executive office of health and human services, in a form and

11

frequency acceptable to the secretary, a report that includes the following data for the years 2021-

12

2029:

13

     (1) For anticonvulsants and antipsychotics;

14

     (i) The annual gross amount spent;

15

     (ii) The annual net amount spent after rebates;

16

     (iv) The average annual cost by class for generic and non-generic anticonvulsant and

17

antipsychotic medications;

18

     (v) The total number of anticonvulsant and antipsychotic medication claims;

19

     (vi) The percentage of adherence to the preferred drug list ("PDL") for anticonvulsant and

20

antipsychotic medications;

21

     (vii) The total number of prior authorizations submitted for nonpreferred anticonvulsant

22

and antipsychotic medications;

23

     (viii) The total number of step therapy exceptions requested for nonpreferred

24

anticonvulsant and antipsychotic medications;

25

     (ix) The total number of step edits per nonpreferred anticonvulsant and antipsychotic

26

medication;

27

     (x) The percentages of prior authorization and step therapy approvals and denials; and

28

     (xi) The generic anticonvulsant and generic antipsychotic medication utilization

29

percentages.

30

     (h) On or before July 1, 2029, the director of the department of health shall collect and

31

provide to the executive office of health and human services, in a form and frequency acceptable

32

to the secretary, a report that includes the following data for the years 2021-2029 from the state and

33

from each of the thirty-nine (39) municipalities:

34

     (1) Gross amount, non-aggregated by entity type, spent on services and personnel related

 

LC004629 - Page 2 of 4

1

to mental health emergencies performed by the following entities:

2

     (i) Ground ambulance transport;

3

     (ii) Air ambulance transport;

4

     (iii) Hospitals, including inpatient and emergency departments;

5

     (iv) Police departments; and

6

     (v) Fire departments.

7

     (i) On or before October 1, 2029, the executive office of health and human services shall

8

produce and provide the information collected pursuant to subsections (g) and (h) of this section to

9

the speaker of the house of representatives, the president of the senate, the house of representatives

10

committee on finance, and the senate committee on health and human services.

11

     (j) The provisions of this section shall sunset and be repealed effective December 31, 2029.

12

     (k) This section applies to all policies, contracts, and plans executed, delivered, issued for

13

delivery, continued or renewed in this state on or after January 1, 2027. This section shall sunset

14

and be repealed on December 31, 2029.

15

     SECTION 2. This act shall take effect on January 1, 2027, and shall sunset and be repealed

16

on December 31, 2029.

========

LC004629

========

 

LC004629 - Page 3 of 4

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO HUMAN SERVICES -- MEDICAL ASSISTANCE -- PRESCRIPTION

DRUGS

***

1

     This act would prohibit the Rhode Island medical assistance program, and any contract

2

between the Rhode Island medical assistance program and a managed care organization, from

3

requiring prior authorization or a step therapy protocol for the coverage of a medication classified

4

as an anticonvulsant or antipsychotic.

5

     This act would take effect on January 1, 2027, and would sunset and be repealed on

6

December 31, 2029.

========

LC004629

========

 

LC004629 - Page 4 of 4